Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: Arthritis Rheum. 2009 Jun 15;61(6):822–829. doi: 10.1002/art.24519

Table 2.

Prevalence and Confidence Intervals of DSM-IV psychiatric disorders among 326 Caucasian women with SLE and population estimates for Caucasian women in the United States.

Psychiatric Disorder* Population Prevalence (%)** (95% CI) Prevalence in SLE sample (%) (95% CI) Age-adjusted prevalence in SLE sample (%) (95% CI)
Major depressive disorder 24.6 (23.5–25.7) 46.91 (41.5–52.3) 42.4 (37.0–47.7)
Bipolar I disorder (Manic-depression) 1.0 (0.5–1.4) 5.81 (3.3–8.4) 4.9 (2.6–7.2)
Dysthymic disorder 5.5 (4.6–6.3) 3.33 (1.4–5.3) 2.9 (1.8–4.7)
Specific phobia 15.8 (14.4–17.2) 23.92 (19.3–28.6) 21.7 (17.3–26.2)
Social anxiety disorder 13.2 (11.8–14.6) 15.6 (11.7–19.6) 14.0 (10.3–17.8)
Panic disorder 6.2 (5.5–6.9) 15.61 (11.7–19.6) 14.7 (10.8–18.5)
Agoraphobia without panic disorder 1.5 (1.1–1.9) 1.2 (0.03–2.4) 0.8 (0–1.8)
Obsessive compulsive disorder 0.8 (0.4–1.2) 8.91 (5.8–12.0) 8.5 (5.5–11.5)
Generalized anxiety disorder 11.1 (10.0–12.1) 4.31 (2.1–6.5) 4.3 (2.1–6.5)
*

Prevalence of any mood or anxiety disorder in SLE sample = 65.0%.

**

Prevalence estimates for psychiatric disorders among white, non-Hispanic females, 18 years and older, in the United States are from the National Comorbidity Survey Replication (NCS-R), n = 3,618 (34).

1

denotes significant difference from population prevalence, p = 0.00001

2

denotes significant difference from population prevalence, p = 0.00009

3

denotes significant difference from population prevalence, p = 0.05

DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.